Clinical Trial

A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

Name: A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects. — clinical trial record (NCT07205198)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety, tolerability of SIBP-A10 and determine the maximum tolerable dose (MTD) and phase II recommended dose (RP2D).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-10-01.

Status change: Not Yet Recruiting → Recruiting 2026-01-06

Trial Details

NCT Number	NCT07205198
Lead Sponsor	Shanghai Institute Of Biological Products
Conditions	Advanced Tumors
Enrollment	160 participants
Start Date	2025-10-31
Primary Completion	2028-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-08